Evidence map›Paper›PMID 27590257›Full record

ReviewBritish journal of pharmacology2017

Vascular actions of relaxin: nitric oxide and beyond.

C H Leo, M Jelinic, H H Ng, S A Marshall, J Novak, M Tare, K P Conrad, L J Parry

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Description of a Large Family with Periodic Fever Carrying a Variant inInternational journal of molecular sciences · 2026
    Article
  7. Review
  8. Review
  9. Liver Fibrosis: Interactions Between Cells and Microenvironments.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.International journal of molecular sciences · 2023
    Article
  15. Heart Rate Variability and Pregnancy Complications: Systematic Review.Interactive journal of medical research · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

C H LeoSchool of BioSciences, The University of Melbourne, Parkville, VIC, Australia.
M JelinicSchool of BioSciences, The University of Melbourne, Parkville, VIC, Australia.
H H NgSchool of BioSciences, The University of Melbourne, Parkville, VIC, Australia.
S A MarshallSchool of BioSciences, The University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0001-7276-1405
J NovakDivision of Mathematics and Science, Walsh University, North Canton, OH, USA.
M TareDepartment of Physiology, Monash University, Clayton, VIC, Australia.
K P ConradDepartment of Physiology and Functional Genomics, Department of Obstetrics and Gynaecology, College of Medicine, University of Florida, Gainesville, FL, USA.
L J ParrySchool of BioSciences, The University of Melbourne, Parkville, VIC, Australia.
The University of Melbourne · AUMonash Health · AUUniversity of Florida · USWalsh University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The peptide hormone relaxin regulates the essential maternal haemodynamic adaptations in early pregnancy through direct actions on the renal and systemic vasculature. These vascular actions of relaxin occur mainly through endothelium-derived NO-mediated vasodilator pathways and improvements in arterial compliance in small resistance-size arteries. This work catalysed a plethora of studies which revealed quite heterogeneous responses across the different regions of the vasculature, and also uncovered NO-independent mechanisms of relaxin action. In this review, we first describe the role of endogenous relaxin in maintaining normal vascular function, largely referring to work in pregnant and male relaxin-deficient animals. We then discuss the diversity of mechanisms mediating relaxin action in different vascular beds, including the involvement of prostanoids, VEGF, endothelium-derived hyperpolarisation and antioxidant activity in addition to the classic NO-mediated vasodilatory pathway. We conclude the review with current perspectives on the vascular remodelling capabilities of relaxin. LINKED ARTICLES: This article is part of a themed section on Recent Progress in the Understanding of Relaxin Family Peptides and their Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.10/issuetoc.

Indexed as

AnimalsEndothelium, VascularHumansNitric OxideRelaxinNitric OxideRelaxin

Identifiers

PMID27590257
PMCPMC5406296
OpenAlexW2516453631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.